Cargando…
Interleukin-6 and intrapulmonary shunt
Based on animal studies and indirect clinical evidence, it may be speculated that IL-6 has a pathophysiological role in intrapulmonary shunt associated to COVID-19 https://bit.ly/3whQVqd
Autores principales: | Perez-Vizcaino, Francisco, Moreno, Laura, Lorente, José A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358234/ https://www.ncbi.nlm.nih.gov/pubmed/34210792 http://dx.doi.org/10.1183/13993003.01292-2021 |
Ejemplares similares
-
Intrapulmonary shunt measured by bedside pulse oximetry predicts worse outcomes in severe COVID-19
por: Kotwica, Aleksandra, et al.
Publicado: (2021) -
Intrapulmonary bronchopulmonary anastomoses in COVID-19 respiratory failure
por: Galambos, Csaba, et al.
Publicado: (2021) -
Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia
por: Larsson, Susanna C., et al.
Publicado: (2021) -
Shunt-type plexiform lesions identified in the Sugen5416/hypoxia rat model of pulmonary arterial hypertension using synchrotron-based phase-contrast micro-CT
por: van der Have, Oscar, et al.
Publicado: (2022) -
Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study
por: Motos, Anna, et al.
Publicado: (2022)